For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Takeda Pharmaceutical Co ADR (NYSE: TAK) closed at $14.44 up 0.07% from its previous closing price of $14.43. In other words, the price has increased by $0.07 from its previous closing price. On the day, 4.39 million shares were traded. TAK stock price reached its highest trading level at $14.58 during the session, while it also had its lowest trading level at $14.415.
Ratios:
For a deeper understanding of Takeda Pharmaceutical Co ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.12. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 1.01. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.65.
On March 16, 2023, BofA Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $20.
Cowen Upgraded its Market Perform to Outperform on July 19, 2022, whereas the target price for the stock was revised from $21 to $24.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 09 ’25 when Thomas Wozniewski bought 6,136 shares for $15.42 per share.
Teresa Marie Bitetti bought 52,649 shares of TAK for $811,848 on Jul 09 ’25. On Jul 09 ’25, another insider, Ramona A Sequeira, who serves as the President, Global Portfolio Di of the company, bought 102,972 shares for $15.42 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TAK now has a Market Capitalization of 46206697472 and an Enterprise Value of 4728700796928. As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 66.45, and their Forward P/E ratio for the next fiscal year is 19.08. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.41. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.51 while its Price-to-Book (P/B) ratio in mrq is 0.98. Its current Enterprise Value per Revenue stands at 1.032 whereas that against EBITDA is 3.834.
Stock Price History:
The Beta on a monthly basis for TAK is 0.26, which has changed by 0.06809771 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, TAK has reached a high of $15.53, while it has fallen to a 52-week low of $12.80. The 50-Day Moving Average of the stock is -2.35%, while the 200-Day Moving Average is calculated to be 1.51%.
Shares Statistics:
For the past three months, TAK has traded an average of 2.25M shares per day and 3080590 over the past ten days. A total of 3.15B shares are outstanding, with a floating share count of 3.15B. Insiders hold about 0.02% of the company’s shares, while institutions hold 5.05% stake in the company. Shares short for TAK as of 1749772800 were 6498112 with a Short Ratio of 2.26, compared to 1747267200 on 6244158. Therefore, it implies a Short% of Shares Outstanding of 6498112 and a Short% of Float of 0.21.
Dividends & Splits
According to the company, the forward annual dividend rate for TAK is 0.33, from 196.0 in the trailing year. Against a Trailing Annual Dividend Yield of 13.582813The stock’s 5-year Average Dividend Yield is 4.69.
